WebAmendment 1 to Employment Agreement between the Company and Jason Smith, dated January 26, 2024 from UroGen Pharma Ltd. filed with the Securities and Exchange … Web5 oct. 2024 · UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Oct 05, 2024 - read this article along with other careers information, tips and advice on BioSpace. ... 2024, and the vesting commencement date for the Options and RSUs granted to Mr. Smith is August 31, 2024. ...
Jason P. Smith, MD - Urology Kaiser Permanente
WebSmith Jason Drew (Last) (First) (Middle) C/O UROGEN PHARMA LTD. 400 ALEXANDER PARK DRIVE (Street) PRINCETON: NJ: 08540 (City) (State) ... Issuer Name and Ticker or Trading Symbol UroGen Pharma Ltd. [ URGN] 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) Other … WebCurrently, Stuart Holden is Chairman of ProQuest Management LLC. Dr. Holden is also on the board of UroGen Pharma Ltd. and Medical Director for Prostate Cancer Foundation and Board Member at American... calling from landline ireland
Jason Drew Smith - URGN / Urogen Pharma Ltd - Insider Trade …
Web12 aug. 2024 · Employment Agreement between the Company and Jason Smith, dated August 12, 2024 from UroGen Pharma Ltd. filed with the Securities and Exchange … WebURGN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for UroGen Pharma Ltd.. Web31 ian. 2024 · Jason Smith has been named General Counsel and Chief Compliance Officer. Mr. Smith comes to UroGen from Pfizer where he spent the last 11 years. Jason … calling from italy to usa